5
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Hemoglobin A1c levels and 1-year mortality in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention

, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 117-122 | Received 04 Oct 2023, Accepted 06 Mar 2024, Published online: 11 Apr 2024

References

  • Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 133(4), e38–e360 (2016).
  • Stone GW, Grines CL, Browne KF et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J. Am. Coll. Cardiol. 25(2), 370–377 (1995).
  • Blendea C, Chitu M, Orzan M, Bajka B, Craciun A, Benedek I. The study of factors associated with severity of in-stent restenosis in patients treated with PCI for acute coronary syndromes. Acta Marisiensis Seria Med. 62(1), 64–67 (2016).
  • Joseph J, Velasco A, Hage FG, Reyes E. Guidelines in review: comparison of ESC and ACC/AHA guidelines for the diagnosis and management of patients with stable coronary artery disease. J. Nucl. Cardiol. 25(2), 509–515 (2018).
  • Nakano Y, Ishikawa T, Mutoh M. Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels. Cardiovasc. Interv. Ther. 30(4), 327–337 (2015).
  • Rosengren A. Cardiovascular disease in diabetes type 2: current concepts. J. Int. Med. 284(3), 240–253 (2018).
  • Chichareon P, Modolo R, Kogame N et al. Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: pre-specified subgroup analysis from the randomized GLOBAL LEADERS study. Atherosclerosis 295, 45–53 (2020).
  • Shahid M, Zarif HMA, Farid MS, Abid MS, Akhtar B, Khan MR. Prognostic value of hyperglycemia on admission on in-hospital outcomes in patients presenting with ST-elevation myocardial infarction. Cureus 12(2), e7024 (2020).
  • Tian L, Zhu J, Liu L, Liang Y, Li J, Yang Y. Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: an observational multicenter study. Coron. Artery Dis. 24(1), 16–22 (2013).
  • Selvin E. Hemoglobin A1c – using epidemiology to guide medical practice: Kelly West Award lecture 2020. Diabetes Care 44(10), 2197–2204 (2021).
  • Li S, Nemeth I, Donnelly L, Hapca S, Zhou K, Pearson ER. Visit-to-visit HbA1c variability is associated with cardiovascular disease and microvascular complications in patients with newly diagnosed type 2 diabetes. Diabetes Care 43(2), 426–432 (2020).
  • Eskesen K, Jensen M, Galatius S et al. Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all-cause mortality in the Copenhagen City Heart Study. J. Int. Med. 273(1), 94–101 (2013).
  • Khaw K-T, Wareham N, Luben R et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322(7277), 15 (2001).
  • Ray KK, Seshasai SRK, Wijesuriya S et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373(9677), 1765–1772 (2009).
  • Albugami S, Almehmadi F, Bukhari ZM et al. Glycated haemoglobin and outcomes of percutaneous coronary intervention among type two diabetic patients in Saudi Arabia. Cureus 12(10), e11278 (2020).
  • Hwang JK, Lee SH, Song YB et al. Glycemic control status after percutaneous coronary intervention and long-term clinical outcomes in patients with type 2 diabetes mellitus. Circ. Cardiovasc. Interv. 10(4), e004157 (2017).
  • Baber U, Azzalini L, Masoomi R et al. Hemoglobin A1c and cardiovascular outcomes following percutaneous coronary intervention: insights from a large single-center registry. Cardiovasc. Interv. 14(4), 388–397 (2021).
  • Li Y, Li X-W, Zhang Y-H et al. Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis. Chin. Med. J. 133(18), 2229–2235 (2020).
  • Sharma PK, Agarwal S, Ellis SG et al. Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention. Circ. Cardiovasc. Interv. 7(4), 503–509 (2014).
  • de Miguel-Yanes JM, Jiménez-García R, Hernandez-Barrera V et al. Sex differences in the incidence and outcomes of acute myocardial infarction in Spain, 2016–2018: a matched-pair analysis. J. Clin. Med. 10(8), 1795 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.